• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

CCC07-01

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3603530

CCC07-01 (CCC 0701) is a novel alkylating compound that is capable of disrupting expression of PD-1, PD-L1 and CTLA-4 genes with IC50 of 15, 10 and 5 nM in cell-base assays. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
CCC07-01, Biochemical
Full Product Name
CCC07-01
Product Synonym Names
CCC 07-01; CCC 0701
Purity/Purification
>98% (HPLC)
Preparation and Storage
Store at -20 degree C
Stability: >=2 years
Shipping: Ice Pack
Molecular Weight
1886.378
Target
PD-1/PD-L1
Receptor
PD-1/PD-L1
Molecular Formula
C90H93ClN30O16
CAS Number
2215102-35-3

Product Categories/Family for CCC07-01 biochemical

Structure of CCC07-01 biochemical

CCC07-01 Biochemical – Cat# MBS3603530

Product References and Citations for CCC07-01 biochemical

1. US Patent WO 2018056361.
2. Horiki Nagase, et al. 2018 AACR #2711: Development of a new innovative multifunctional immune checkpoint inhibitor.

Other Notes

Small volumes of CCC07-01 biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for CCC07-01 purchase

MBS3603530 is a biochemical targeting CCC07-01.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000